financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Keeps Buy Opinion On Shares Of Imperial Oil
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Keeps Buy Opinion On Shares Of Imperial Oil
May 26, 2025 3:10 AM

02:45 AM EDT, 05/06/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

Our 12-month target price of CAD108, cut by CAD5, reflects a 7.7x multiple of enterprise value to projected 2026 EBITDA, in line with IMO's historical forward average. We raised our 2025 EPS estimate by CAD0.64 to CAD8.32, and raised 2026's by CAD0.11 to CAD8.61. We note that IMO benefited in the quarter from a narrowing of the spread between U.S. WTI crude oil and the Canadian counterpart, Western Canada Select. As a result, even though WTI prices declined in Q1 vs. the year-ago quarter, IMO's realized pricing actually improved. We note that IMO is also conducting some planned turnaround activity in 2025, which should help boost results in 2026. The threat of U.S. tariffs on Canadian oil is a bit of a wildcard, which, if implemented, would likely weigh on U.S. refined product demand (and thus demand for IMO's barrels). Nonetheless, we like the risk-reward balance on IMO. Shares yield 3.1%.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Maintains Buy Opinion On Shares Of Constellation Brands Inc.
Research Alert: CFRA Maintains Buy Opinion On Shares Of Constellation Brands Inc.
Oct 7, 2025
11:50 AM EDT, 10/07/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lower our 12-month target by $10 to $175, based on a 2027 P/E of 13.7x, a steep but justified discount to STZ's 10-year average forward P/E of 21.6x. We...
Research Alert: CFRA Lowers Opinion On Lucid Group Inc. Shares To Strong Sell From Sell
Research Alert: CFRA Lowers Opinion On Lucid Group Inc. Shares To Strong Sell From Sell
Oct 7, 2025
08:20 AM EDT, 10/07/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We maintain our 12-month target of $10. We lower our adjusted EPS estimates to -$11.15 from -$10.50 for 2025 and to -$11.50 from -$11.00 for 2026. LCID posted Q3 vehicle...
Research Alert: CFRA Raises Opinion On Health Care To Marketweight From Underweight
Research Alert: CFRA Raises Opinion On Health Care To Marketweight From Underweight
Oct 8, 2025
01:40 PM EDT, 10/08/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: After Pfizer Inc. (PFE 26 ****) and the U.S. government struck the first Most Favored Nation (MFN) drug pricing deal to lower drug prices in the U.S., we see policy...
Research Alert: CFRA Keeps Sell Opinion On Shares Of Mccormick & Company, Incorporated
Research Alert: CFRA Keeps Sell Opinion On Shares Of Mccormick & Company, Incorporated
Oct 7, 2025
02:30 PM EDT, 10/07/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lower our 12-month target by $1 to $59, about 19x our FY 26 (Nov.) EPS estimate of $3.12 (down from $3.14; FY 25 raised to $3.03 from $2.97). This...
Copyright 2023-2025 - www.financetom.com All Rights Reserved